藥品參考
Glatiramer
Glatiramer is a medicine in the class central nervous system. It is used for multiple sclerosis.
- 藥物類別: Central Nervous System
- 用途: multiple sclerosis
最後更新 來源: US FDA label
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Central Nervous System
- 常見劑型
- 注射劑
- 常見規格
- 20 mg/ml, 40 mg/ml
- 已知交互作用
- 18 (輕微: 18)
- 商品名
- 4
- 國家與市場
- 2
用途
作用方式
Mechanism in MS is not fully understood; thought to act by modifying immune processes believed responsible for MS pathogenesis. Animal and in vitro studies suggest induction and activation of glatiramer acetate-specific suppressor T-cells in the periphery.
成人常用劑量（仿單摘要）
Relapsing forms of multiple sclerosis: Glatopa 20 mg per mL, subcutaneous, once per day
懷孕與哺乳
- 懷孕
- Unknown Pharmacovigilance and observational data have not identified a drug-associated risk of major birth defects, miscarriage, or adverse outcomes; no adverse effects in rats or rabbits.
- 哺乳
- Unknown No data on presence in human milk; low systemic exposure means clinically relevant infant exposure is not expected. Weigh benefits of breastfeeding against maternal need.
已通報的副作用
- Injection site erythema
- Injection site pain
- Injection site pruritus
- Injection site mass
- Vasodilatation
- Rash
黑框警語
- Life-threatening and fatal anaphylaxis has been reported, and can occur at any time after starting therapy, from after the first dose to years later. Make patients aware of symptoms, which may overlap with immediate post-injection reaction, and instruct them to seek immediate medical care. Contraindicated in patients with prior hypersensitivity, including anaphylaxis. If anaphylaxis occurs, discontinue immediately and permanently unless a clear alternative etiology is identified.
禁忌症
- Known hypersensitivity to glatiramer acetate or mannitol; reactions have included anaphylaxis.
哪些人需要特別留意
- Immediate post-injection reaction (flushing, chest pain, palpitations, tachycardia, anxiety, dyspnea, throat constriction, urticaria) may occur within seconds to minutes after injection; usually transient.
- Transient chest pain may occur, often unrelated to injection.
- Lipoatrophy and rarely skin necrosis may occur at injection sites; lipoatrophy is thought to be permanent. Use proper technique and rotate sites.
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
重要交互作用 (18)
- Anakinra + Glatiramer Minor
- Anti-thymocyte + Glatiramer Minor
- Basiliximab + Glatiramer Minor
- Denosumab + Glatiramer Minor
- Echinacea + Glatiramer Minor
- Etanercept + Glatiramer Minor
- Glatiramer + Golimumab Minor
- Glatiramer + Hepatitis A vaccine inactivated Minor
- Glatiramer + Human papillomavirus vaccine Minor
- Glatiramer + Leflunomide Minor
同類別的其他藥品
常見問題
What is Glatiramer used for?
Glatiramer is a medicine in the class central nervous system. It is used for Multiple sclerosis.
What side effects have been reported with Glatiramer?
Injection site erythema, Injection site pain, Injection site pruritus, Injection site mass, Vasodilatation, Rash. Serious warning: Life-threatening and fatal anaphylaxis has been reported, and can occur at any time after starting therapy, from after the first dose to years later.
Can Glatiramer be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Pharmacovigilance and observational data have not identified a drug-associated risk of major birth defects, miscarriage, or adverse outcomes; no adverse effects in rats or rabbits. Breastfeeding: Unknown. No data on presence in human milk; low systemic exposure means clinically relevant infant exposure is not expected. Weigh benefits of breastfeeding against maternal need.
What does Glatiramer interact with?
MediHelp lists 18 known interactions for Glatiramer. Minor: 18. The most serious include Anakinra, Anti-thymocyte, Basiliximab.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
